Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 12.80
+0.40 (3.23%)
Last updated: Mar 18, 2026, 4:10 PM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €97.81 million as of March 18, 2026. Its market cap has increased by 387.66% in one year.
Market Cap
97.81M
Enterprise Value
95.95M
Revenue
8.09M
Ranking
n/a
PE Ratio
50.10
Stock Price
€12.80
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 97.81M, an increase of 536.45%. That is a compound annual growth rate of 58.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 93.30M | 45.03% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.71B |
| Laboratorios Farmaceuticos Rovi | 4.09B |
| Almirall | 2.46B |
| Pharma Mar | 1.50B |
| Atrys Health | 223.07M |
| Oryzon Genomics | 221.69M |
| Prim, S.A. | 217.80M |
| Laboratorio Reig Jofre | 191.32M |